相关实验视频
Updated: Jun 23, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
帕金森病患者对伊斯特拉德菲林的坚持:基于小组的轨迹分析
Toshiki Fukasawa1, Etsuro Nakanishi2, Hiroo Shimoda3
1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan; Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Journal of the neurological sciences
|June 26, 2024
概括
对帕金森病患者来说,了解对伊斯特拉德菲林的坚持是关键. 确定了四种不同的坚持模式,与不同相关的患者特征,突出了个性化干预的需要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 数据科学数据科学数据科学
背景情况:
- 坚持伊斯特拉德菲林治疗对于帕金森病 (PD) 管理至关重要.
- 识别不同的坚持模式可以指导PD患者的有针对性的干预措施.
研究的目的:
- 在帕金森病患者中确定伊斯特拉德菲林的纵向粘附模式.
- 描述与不同的伊斯特拉德菲林粘附模式相关的因素.
主要方法:
- 利用日本医院管理数据库来识别PD患者开始用伊斯特拉德菲林.
- 采用基于小组的轨迹建模来定义360天的坚持模式.
- 评估了与坚持模式相关的因素,使用无变量的多项逻辑回归.
主要成果:
- 确定了四个不同的坚持群体:始终高 (56.8%),快速下降 (25.8%),逐渐下降 (8.5%),下降然后恢复 (9.0%).
- 较低的坚持群体在同时使用药物 (多巴胺激动剂,MAO-B抑制剂) 和焦虑/情绪障碍或轻度认知障碍/痴呆症的患病率方面存在差异.
结论:
- 帕金森病中的伊斯特拉德菲林粘附是异质的.
- 临床医生应该认识到这些多样化的坚持模式,以优化患者护理.
相关概念视频
01:24Parkinson's Disease: Treatment
254
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
254
01:15Parkinson's Disease: Overview
523
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
523
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:12Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252